4-aminopyridine and ubiquinone

4-aminopyridine has been researched along with ubiquinone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chang, Y; Lin, YW; Wang, SJ1
Chang, Y; Huang, SK; Wang, SJ1
Chan, JW; Karanjia, R; Sadun, AA; Sultan, W1

Other Studies

3 other study(ies) available for 4-aminopyridine and ubiquinone

ArticleYear
Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 384, Issue:1

    Topics: 4-Aminopyridine; Animals; Aspartic Acid; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbazoles; Cerebral Cortex; Clonazepam; Cyclic AMP-Dependent Protein Kinases; Dantrolene; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Indoles; Isoquinolines; Macrolides; Male; Maleimides; Membrane Potentials; Nerve Endings; omega-Conotoxins; Potassium; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Sulfonamides; Synaptosomes; Thiazepines; Ubiquinone

2011
Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
    Journal of agricultural and food chemistry, 2012, Dec-05, Volume: 60, Issue:48

    Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cerebral Cortex; Clonazepam; Dantrolene; Glutamic Acid; Macrolides; Male; MAP Kinase Signaling System; Membrane Potentials; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Nerve Endings; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Synapsins; Synaptosomes; Thiazepines; Ubiquinone

2012
Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
    Mitochondrion, 2022, Volume: 62

    Topics: 4-Aminopyridine; Adult; DNA, Mitochondrial; Drug Therapy, Combination; Humans; Male; Nerve Net; Neurons; Optic Atrophy, Hereditary, Leber; Retrospective Studies; Ubiquinone; Young Adult

2022